ConductScience.org, home

Paper19861964

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.

Board RE and 11 others. Br J Cancer, 2009. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Papers, record 19861964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19861964

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.
PubMed
Journal
Br J Cancer
PubMed
Year
2009
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
1.61
iCite
Revised in PubMed
2021-10-20
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Board RER E
2Ellison GG
3Orr MCM C M
4Kemsley KRK R
5McWalter GG
6Blockley LYL Y
7Dearden SPS P
8Morris CC
9Ranson MM
10Cantarini MVM V
11Dive CC
12Hughes AA

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenzimidazolesMajor topic
MelanomaMajor topic
MutationMajor topic
Proto-Oncogene Proteins B-rafMajor topic
Skin NeoplasmsMajor topic
Antineoplastic Agents
Cell Line, Tumor
DNA Mutational Analysis
DNA, Neoplasm
Disease-Free Survival
HT29 Cells
Humans
Prognosis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04158544Immune Monitoring in Metastatic MelanomaBackground

Source ClinicalTrials.gov

Download CSV of trials

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117315191Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.Int J Cancer2007https://conductscience.org/library/papers/17315191PubMed
216368947Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.J Natl Cancer Inst2005https://conductscience.org/library/papers/16368947PubMed
317404088Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy.Clin Cancer Res2007https://conductscience.org/library/papers/17404088PubMed
48052857Transformation of mammalian cells by constitutively active MAP kinase kinase.Science1994https://conductscience.org/library/papers/8052857PubMed
52785681Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).Nucleic Acids Res1989https://conductscience.org/library/papers/2785681PubMed
610454649Optimisation of DNA and RNA extraction from archival formalin-fixed tissue.Nucleic Acids Res1999https://conductscience.org/library/papers/10454649PubMed
718670422Circulating mutant DNA to assess tumor dynamics.Nat Med2008https://conductscience.org/library/papers/18670422PubMed
812460918BRAF and RAS mutations in human lung cancer and melanoma.Cancer Res2002https://conductscience.org/library/papers/12460918PubMed
916818687Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.Clin Cancer Res2006https://conductscience.org/library/papers/16818687PubMed
1014695152NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.Clin Cancer Res2003https://conductscience.org/library/papers/14695152PubMed
1115373800Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.J Invest Dermatol2004https://conductscience.org/library/papers/15373800PubMed
1215613230Clinical significance of BRAF mutations in metastatic melanoma.J Transl Med2004https://conductscience.org/library/papers/15613230PubMed
1317848912Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).Br J Cancer2007https://conductscience.org/library/papers/17848912PubMed
1417332304Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor.Clin Cancer Res2007https://conductscience.org/library/papers/17332304PubMed
1512068308Mutations of the BRAF gene in human cancer.Nature2002https://conductscience.org/library/papers/12068308PubMed
1617384209Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.J Mol Diagn2007https://conductscience.org/library/papers/17384209PubMed
1710873061Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer.Clin Cancer Res2000https://conductscience.org/library/papers/10873061PubMed

Download CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
37450124The Value of Cell-Free Circulating DNA Profiling in Patients with Skin Diseases.Methods Mol Biol2023https://conductscience.org/library/papers/37450124PubMed
36620597Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect.Front Oncol2022https://conductscience.org/library/papers/36620597PubMed
36276290Evaluating the Diagnostic Potentials of Circulating Tumor DNA against Melanoma: A Systematic Review and Meta-Analysis.J Oncol2022https://conductscience.org/library/papers/36276290PubMed
34703985BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance).Mayo Clin Proc Innov Qual Outcomes2021https://conductscience.org/library/papers/34703985PubMed
34035810Prognostic Value of ctDNA Mutation in Melanoma: A Meta-Analysis.J Oncol2021https://conductscience.org/library/papers/34035810PubMed
33091721Adaptive redox homeostasis in cutaneous melanoma.Redox Biol2020https://conductscience.org/library/papers/33091721PubMed
32695793The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape.Front Mol Biosci2020https://conductscience.org/library/papers/32695793PubMed
30487597The ERK and JNK pathways in the regulation of metabolic reprogramming.Oncogene2019https://conductscience.org/library/papers/30487597PubMed
28484715Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.Biomed Res Int2017https://conductscience.org/library/papers/28484715PubMed
27895798Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay.Oncol Lett2016https://conductscience.org/library/papers/27895798PubMed
27259537Somatic mutations in histiocytic sarcoma identified by next generation sequencing.Virchows Arch2016https://conductscience.org/library/papers/27259537PubMed
27249771Tumor Heterogeneity and Therapeutic Resistance.Am Soc Clin Oncol Educ Book2016https://conductscience.org/library/papers/27249771PubMed
26697469cfDNA analysis from blood in melanoma.Ann Transl Med2015https://conductscience.org/library/papers/26697469PubMed
26631873Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma.J Mol Diagn2016https://conductscience.org/library/papers/26631873PubMed
26562020SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.PLoS One2015https://conductscience.org/library/papers/26562020PubMed
26347132Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2.Drugs2015https://conductscience.org/library/papers/26347132PubMed
26258049Detection of BRAF mutations from solid tumors using Tumorplex™ technology.MethodsX2015https://conductscience.org/library/papers/26258049PubMed
25122430Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status.J Thorac Oncol2014https://conductscience.org/library/papers/25122430PubMed
24759937DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Analyst2014https://conductscience.org/library/papers/24759937PubMed
24446311BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS.Am J Hematol2014https://conductscience.org/library/papers/24446311PubMed

See all 44 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19861964

GET https://conductscience.org/api/papers/v1/19861964/cited_by?page=2